Skip to main content

GREAT VALLEY ADVISOR GROUP, INC.

Position in JNJ — Johnson & Johnson

CIK 1769897 WILMINGTON, DE

Position in JNJ

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$17,439,865
+$989,787 QoQ
Shares Held
68,669
+2.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#803
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Dec 31, 2020
CallValue
$125,904
CallShares
800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GREAT VALLEY ADVISOR GROUP, INC. holds $83,001,641 across 13 Drug Manufacturers - General names. JNJ ranks #3 (21.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 JNJ
Johnson & Johnson
This page
68,669 $17,439,865

All Filings in JNJ

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,439,865 68,669
2026-03-31 $16,450,078 67,297
2025-12-31 $14,455,871 69,852
2025-09-30 $12,766,908 68,854
2025-06-30 $10,175,746 66,617
2025-03-31 $11,515,100 69,435
2024-12-31 $13,041,108 90,175
2024-09-30 $21,439,079 132,291
2024-06-30 $16,057,137 109,860
2024-03-31 $15,666,504 99,036
2023-12-31 $15,826,037 100,970
2023-09-30 $14,540,352 93,357
2023-06-30 $15,154,514 91,557
2023-03-31 $13,510,265 87,163
2022-12-31 $12,106,884 68,536
2022-09-30 $11,281,968 69,062
2022-06-30 $12,049,378 67,880
2022-03-31 $9,510,870 53,664
2021-12-31 $8,933,446 52,221
2021-09-30 $6,646,694 41,156
2021-06-30 $6,999,473 42,488
2021-03-31 $7,039,439 42,832
2020-12-31 $125,904 800
2020-12-31 $6,639,704 42,189
2020-09-30 $5,781,754 38,835
2020-09-30 $119,104 800
2020-06-30 $19,000 40,000
2020-06-30 $4,687,197 33,330
2020-03-31 $3,716,355 28,341